Physician

Vidya Seshadri, M.D.

According to 2025 Medicare claims, Vidya Seshadri, M.D. (NPI: 1184843369) practices hematology/oncology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-1759. Seshadri is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Seshadri's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 851 traditional Medicare patients, billed 334,021 HCPCS/CPT codes, and received $4,418,673 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,216 prescription claims across 450 beneficiaries totaling $6,328,473 in drug costs, led by Pomalyst (Pomalidomide). DME data shows 78 claims. Open Payments data shows 220 records totaling $4,522. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,805,978 to $4,418,673. Similarly, Part D prescription costs have risen steadily, from $2,254,404 to $6,328,473. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $12,469 to $977.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	699	149,935	$1,805,978
2016	755	202,825	$2,106,263
2017	742	251,208	$3,134,114
2018	741	241,531	$3,411,720
2019	720	241,103	$2,844,861
2020	724	300,759	$3,738,795
2021	635	249,991	$3,367,342
2022	630	265,320	$4,531,992
2023	751	336,181	$4,688,802
2024	851	334,021	$4,418,673

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	285	1,688	$2,254,404
2016	341	2,105	$3,397,089
2017	362	2,540	$3,984,710
2018	372	2,562	$4,027,978
2019	400	2,536	$4,465,927
2020	410	2,706	$6,392,826
2021	380	2,412	$5,875,766
2022	338	1,981	$5,004,998
2023	377	1,932	$4,700,329
2024	450	2,216	$6,328,473

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	27	163	$30,321
2016	17	237	$52,371
2017	14	130	$21,008
2018	25	129	$20,539
2019	13	122	$12,423
2020	36	260	$17,170
2021	38	139	$8,394
2022	37	144	$5,718
2023	22	129	$25,796
2024	13	78	$3,398

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	393	656	$92
82728	Ferritin (blood protein) level	273	634	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	379	655	$12
80053	Blood test, comprehensive group of blood chemicals	614	2,323	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	673	2,756	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	40	1,050	$871,903
Revlimid	Lenalidomide	32	847	$517,332
Lenalidomide	Lenalidomide	35	868	$460,122
Fotivda	Tivozanib Hcl	14	392	$416,850
Orserdu	Elacestrant Hcl	17	510	$375,978

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
L8000	Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any type	N	13	19	$2,106
J8521	Capecitabine, oral, 500 mg	N	N/R	27	$904
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	32	$389

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	220	$4,522	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vidya Seshadri, M.D.?

Tedicare shows public-source Medicare data for Vidya Seshadri, M.D. (NPI 1184843369), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vidya Seshadri, M.D. have ACO affiliation data?

Vidya Seshadri, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Vidya Seshadri, M.D.?

Vidya Seshadri, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Vidya Seshadri, M.D. have Open Payments data?

Vidya Seshadri, M.D. has 220 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.